-
公开(公告)号：US09085559B2
公开(公告)日：2015-07-21
申请号：US13321445
申请日：2010-12-31
申请人： Vasanta Madhava Sharma Gangavaram , Jhillu Singh Yadav , Radha Krishna Palakodety , Arun Bandyopadhyay , Siddhartha Roy , Santu Bandyopadhyay , Rakesh Kamal Johri , Subhash Chander Sharma , Balaram Ghosh , Mabalirajan Ulaganathan , Sakshi Balwani , Bholanath Paul , Ashok Kumar Saxena
发明人： Vasanta Madhava Sharma Gangavaram , Jhillu Singh Yadav , Radha Krishna Palakodety , Arun Bandyopadhyay , Siddhartha Roy , Santu Bandyopadhyay , Rakesh Kamal Johri , Subhash Chander Sharma , Balaram Ghosh , Mabalirajan Ulaganathan , Sakshi Balwani , Bholanath Paul , Ashok Kumar Saxena
IPC分类号： C07D403/14 , C07D251/50 , C07D251/52 , A61K31/53 , A61P11/06
CPC分类号： C07D403/14 , A61K31/53 , C07D251/50 , C07D251/52
摘要： A novel heterocyclic compound belonging to ‘triazine-aryl-bis-indoles’, useful for the treatment of asthma. The pathway by which this compound inhibits asthma is also demonstrated. The present invention also provides a process for the preparation of above compounds and their derivatives are presented.
摘要翻译： 属于“三嗪 - 芳基 - 双 - 吲哚”的新型杂环化合物，可用于治疗哮喘。 还证明了该化合物抑制哮喘的途径。 本发明还提供了制备上述化合物的方法及其衍生物。
-
公开(公告)号：US08519154B2
公开(公告)日：2013-08-27
申请号：US13365979
申请日：2012-02-03
申请人： Sibabrata Mukhopadhyay , Mumu Chakraborty , Tulika Mukherjee , Arun Bandyopadhyay , Dipak Kar , Tanima Banerjee , Aditya Konar , Debaprasad Jana , Siddhartha Roy , Santu Bandyopadhyay , Balram Ghosh , Mabalirajan Ulaganathan , Rakesh Kamal Johri , Subhash Chander Sharma , Gurdarshan Singh , Bholanath Paul , Vasanta Madhava Sharma Gangavaram , Jhillu Singh Yadav , Radha Krishna Palakodety
发明人： Sibabrata Mukhopadhyay , Mumu Chakraborty , Tulika Mukherjee , Arun Bandyopadhyay , Dipak Kar , Tanima Banerjee , Aditya Konar , Debaprasad Jana , Siddhartha Roy , Santu Bandyopadhyay , Balram Ghosh , Mabalirajan Ulaganathan , Rakesh Kamal Johri , Subhash Chander Sharma , Gurdarshan Singh , Bholanath Paul , Vasanta Madhava Sharma Gangavaram , Jhillu Singh Yadav , Radha Krishna Palakodety
IPC分类号： C07D209/82 , C07D209/88 , A61K31/403
CPC分类号： C07D209/86 , A61K31/404
摘要： The present invention relates to a method for the treatment of bronchial asthma and chronic obstructive pulmonary disease (COPD) comprising administering to the patient suffering from asthma and COPD an effective dose of carbazole derivatives or salt thereof, optionally along with pharmaceutically acceptable excipients.Structural formula of the compounds of general formula 1 useful as phosphodiesterase-4 (PDE-4) enzyme inhibitors, inhibitor for signalling molecule for the treatment of asthma and asthma related diseases is given below: wherein R1=H or OCH3; R2═CH3 or CHO; R3═H or OCH3; R4═H or OCH3 Herbal route for the isolation of compound of general formula 1 from the bark of plant Murraya Koenigii and chemical route for the preparation of such compounds from basic compounds such as vanillin is also reported.
摘要翻译： 本发明涉及一种治疗支气管哮喘和慢性阻塞性肺疾病（COPD）的方法，其包括向患有哮喘和COPD的患者施用有效剂量的咔唑衍生物或其盐，任选地与药学上可接受的赋形剂。 用作磷酸二酯酶-4（PDE-4）酶抑制剂的通式1化合物的结构式，用于治疗哮喘和哮喘相关疾病的信号分子抑制剂如下：其中R1 = H或OCH3; R2 = CH3或CHO; R3 = H或OCH3; R4 = H或OCH3用于从植物Murraya Koenigii的树皮中分离通式1的化合物的草药路线以及用于从碱性化合物如香草醛制备这些化合物的化学途径也被报道。
-
公开(公告)号：US20120202868A1
公开(公告)日：2012-08-09
申请号：US13365979
申请日：2012-02-03
申请人： Sibabrata MUKHOPADHYAY , Mumu CHAKRABORTY , Tulika MUKHERJEE , Arun BANDYOPADHYAY , Dipak KAR , Tanima BANERJEE , Aditya KONAR , Debaprasad JANA , Siddhartha ROY , Santu BANDYOPADHYAY , Balram GHOSH , Mabalirajan ULAGANATHAN , Rakesh Kamal JOHRI , Subhash Chander SHARMA , Gurdarshan SINGH , Bholanath PAUL , Vasanta Madhava Sharma GANGAVARAM , Jhillu Singh YADAV , Radha Krishna PALAKODETY
发明人： Sibabrata MUKHOPADHYAY , Mumu CHAKRABORTY , Tulika MUKHERJEE , Arun BANDYOPADHYAY , Dipak KAR , Tanima BANERJEE , Aditya KONAR , Debaprasad JANA , Siddhartha ROY , Santu BANDYOPADHYAY , Balram GHOSH , Mabalirajan ULAGANATHAN , Rakesh Kamal JOHRI , Subhash Chander SHARMA , Gurdarshan SINGH , Bholanath PAUL , Vasanta Madhava Sharma GANGAVARAM , Jhillu Singh YADAV , Radha Krishna PALAKODETY
IPC分类号： A61K31/403 , A61P11/06 , C07D209/86
CPC分类号： C07D209/86 , A61K31/404
摘要： The present invention relates to a method for the treatment of bronchial asthma and chronic obstructive pulmonary disease (COPD) comprising administering to the patient suffering from asthama and COPD an effective dose of carbazole derivatives or salt thereof, optionally along with pharmaceutically acceptable excipients. Structural formula of the compounds of general formula 1 useful as phosphodiesterase-4 (PDE-4) enzyme inhibitors, inhibitor for signalling molecule for the treatment of asthma and asthma related diseases is given below: wherein R1=H or OCH3; R2═CH3 or CHO; R3═H or OCH3; R4═H or OCH3 Herbal route for the isolation of compound of general formula 1 from the bark of plant Murraya Koenigii and chemical route for the preparation of such compounds from basic compounds such as vanillin is also reported.
摘要翻译： 本发明涉及一种治疗支气管哮喘和慢性阻塞性肺疾病（COPD）的方法，其包括向患有哮喘和COPD的患者施用有效剂量的咔唑衍生物或其盐，任选地与药学上可接受的赋形剂。 用作磷酸二酯酶-4（PDE-4）酶抑制剂的通式1化合物的结构式，用于治疗哮喘和哮喘相关疾病的信号分子抑制剂如下：其中R1 = H或OCH3; R2 = CH3或CHO; R3 = H或OCH3; R4 = H或OCH3用于从植物Murraya Koenigii的树皮中分离通式1的化合物的草药途径以及用于从碱性化合物如香草醛制备这些化合物的化学途径也被报道。
-
公开(公告)号：US20120283263A1
公开(公告)日：2012-11-08
申请号：US13321445
申请日：2010-12-31
申请人： Vasanta Madhava Sharma Gangavaram , Jhillu Singh Yadav , Radha Krishna Palakodety , Arun Bandyopadhyay , Siddhartha Roy , Santu Bandyopadhyay , Rakesh Kamal Johri , Subhash Chander Sharma , Balaram Ghosh , Mabalirajan Ulaganathan , Sakshi Balwani , Bholanath Paul , Ashok Kumar Saxena
发明人： Vasanta Madhava Sharma Gangavaram , Jhillu Singh Yadav , Radha Krishna Palakodety , Arun Bandyopadhyay , Siddhartha Roy , Santu Bandyopadhyay , Rakesh Kamal Johri , Subhash Chander Sharma , Balaram Ghosh , Mabalirajan Ulaganathan , Sakshi Balwani , Bholanath Paul , Ashok Kumar Saxena
IPC分类号： A61K31/53 , A61P11/06 , C12Q1/18 , C07D403/14
CPC分类号： C07D403/14 , A61K31/53 , C07D251/50 , C07D251/52
摘要： A novel heterocyclic compound belonging to ‘triazine-aryl-bis-indoles’, useful for the treatment of asthma. The pathway by which this compound inhibits asthma is also demonstrated. The present invention also provides a process for the preparation of above compounds and their derivatives are presented.
摘要翻译： 属于三嗪 - 芳基 - 双 - 吲哚的新型杂环化合物，可用于治疗哮喘。 还证明了该化合物抑制哮喘的途径。 本发明还提供了制备上述化合物的方法及其衍生物。
-
5.发明授权公开(公告)号：US07001982B2
公开(公告)日：2006-02-21
申请号：US10403815
申请日：2003-03-31
申请人： Gangavaram Vasantha Madhava Sharma , Kondireddi Ravinder Reddy , Radha Krishna Palakodety , Ajit Chand Kunwar , Ravi Sankar Ampapathi , Jagannadh Bulusu , Jayaprakash Pagadala
发明人： Gangavaram Vasantha Madhava Sharma , Kondireddi Ravinder Reddy , Radha Krishna Palakodety , Ajit Chand Kunwar , Ravi Sankar Ampapathi , Jagannadh Bulusu , Jayaprakash Pagadala
CPC分类号： C07D493/04 , C07C237/22 , Y10S930/29
摘要： Nonnatural C-linked carbo-β-peptides with robust secondary structures, which involves the synthesis of a new class of β-peptides called C-linked carbo-β-peptides. The compounds are favorably disposed for the formation of stable helical structures and are useful as biologically active carbo-β-peptides. The new class of β-peptides have the following formula The new class of β-peptides are useful as biologically active molecules to disrupt biological interactions of proteins, for molecular design and to synthesize peptide libraries.
摘要翻译： 具有强烈二级结构的非天然C连接的碳-β-肽，其涉及合成称为C-连接的碳-β-肽的新类型的β-肽。 该化合物有利地用于形成稳定的螺旋结构，并且可用作生物活性的碳-β-肽。 新类型的β-肽具有以下化学式：化学式id =“CHEM-US-00001”num =“000”
-
-
-
-
搜索结果
5 条记录 (耗时 0.012 秒)
